Drugs / KN5601-K
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07283315 | Dec 2025 → Dec 2028 expected | autoimmune disease | The Children's Hospital of Zhejiang University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KN5601-K | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07283315 ↗ |
| Modality | Cell therapy | “anti-CD19/BCMA CAR-NK Cells” NCT07283315 ↗ |
| Route | Other | “anti-CD19/BCMA CAR NK cells infusion” NCT07283315 ↗ |
| Target | CD19 | “anti-CD19/BCMA CAR NK cells” NCT07283315 ↗ |